| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-130-12-199906150-00003 |
| P698 | PubMed publication ID | 10383366 |
| P50 | author | Walter C. Willett | Q1133904 |
| Alberto Ascherio | Q67175546 | ||
| Meir J. Stampfer | Q80164992 | ||
| Ichiro Kawachi | Q16770280 | ||
| Edward L. Giovannucci | Q20740896 | ||
| Miguel Hernán | Q30069782 | ||
| Eric Rimm | Q59660391 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin C | Q199678 | ||
| P304 | page(s) | 963-970 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. | |
| P478 | volume | 130 |
| Q35799977 | A naturally occurring carotenoid, lutein, reduces PDGF and H₂O₂ signaling and compromised migration in cultured vascular smooth muscle cells |
| Q28743884 | A prospective study of aspirin use and the risk of gastrointestinal bleeding in men |
| Q46991418 | Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals |
| Q35823564 | An ideal ocular nutritional supplement? |
| Q33409365 | Astaxanthin reduces ischemic brain injury in adult rats. |
| Q33497323 | Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study |
| Q51527111 | Cardiovascular benefits of lycopene: fantasy or reality? |
| Q42285316 | Carotenoids as Potential Antioxidant Agents in Stroke Prevention: A Systematic Review. |
| Q37188900 | Diet and Neuroimaging Markers of Cerebrovascular Disease |
| Q37738379 | Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies |
| Q59329594 | Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies |
| Q40126265 | Dietary intake of antioxidant vitamins and risk of stroke: the Japan Public Health Center-based Prospective Study |
| Q37486846 | Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. |
| Q34554520 | Dried fruits: excellent in vitro and in vivo antioxidants |
| Q37074895 | Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial. |
| Q34533314 | Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient |
| Q34333996 | Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis |
| Q34107394 | Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress. |
| Q43656750 | Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study |
| Q51246842 | Low vitamin and carotenoid levels are related to cerebral white matter lesions. |
| Q36004071 | Lutein and zeaxanthin and their potential roles in disease prevention |
| Q38629099 | Lycopene and Tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence |
| Q54073609 | Lycopene and risk of cardiovascular diseases: A meta-analysis of observational studies. |
| Q34874340 | Marine carotenoids: biological functions and commercial applications. |
| Q59284185 | Mediterranean Diet and Stroke: Objectives and Design of the SUN Project |
| Q34014678 | Melatonin: an established antioxidant worthy of use in clinical trials. |
| Q34320074 | Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity |
| Q91773901 | Neuroinflammation: friend and foe for ischemic stroke |
| Q34199957 | Nonesterified fatty acids in blood pressure control and cardiovascular complications |
| Q34588811 | Nutrition and disease: challenges of research design |
| Q35830086 | Nutrition and prevention of ischemic stroke: present knowledge, limitations and future perspectives |
| Q35545380 | Nutritional and clinical relevance of lutein in human health |
| Q44872898 | Nutritional intakes of 1072 French free-living men with and without diagnosed cardiovascular risk factors |
| Q36177627 | Place of drug therapy in the treatment of carotid stenosis |
| Q34361581 | Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies |
| Q43857839 | Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity |
| Q43876847 | Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. |
| Q73795430 | Position of the American Dietetic Association: nutrition, aging, and the continuum of care |
| Q36107804 | Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. |
| Q34271974 | Prevention of strokes |
| Q35648904 | Protective effects of vitamin E against hypercholesterolemia-induced age-related diseases |
| Q42952911 | Purified canola lutein selectively inhibits specific isoforms of mammalian DNA polymerases and reduces inflammatory response. |
| Q36860735 | Red orange: experimental models and epidemiological evidence of its benefits on human health |
| Q37629328 | Regulatory metabolites of vitamin E and their putative relevance for atherogenesis |
| Q37008937 | Relationship of lycopene intake and consumption of tomato products to incident CVD. |
| Q32166645 | Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries |
| Q37531010 | Stroke: roles of B vitamins, homocysteine and antioxidants |
| Q45190315 | Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress |
| Q91955668 | Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies |
| Q38735263 | The future of epidemiology: methods or matter? |
| Q43999982 | The intake of carotenoids in an older Australian population: The Blue Mountains Eye Study |
| Q33890743 | Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? |
| Q34851812 | Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding |
| Q34175262 | Vitamin C as an antioxidant: evaluation of its role in disease prevention |
| Q24619695 | Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies |
| Q58545742 | Vitamin E intake and risk of stroke: a meta-analysis |
| Q24654699 | Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial |
| Q43273807 | Vitamins and minerals with antioxidant properties and cardiometabolic risk: controversies and perspectives |
| Q36415199 | Vitamins e and C alleviate the germ cell loss and oxidative stress in cryptorchidism when administered separately but not when combined in rats |
| Q37590718 | Vitamins, Are They Safe? |
| Q40377130 | Walnuts and dietary approaches to the prevention and management of abnormal lipid profiles in Type 2 diabetes mellitus |
| Q73903824 | [Should antioxidants be recommended for the prevention of cardiovascular diseases?] |
| Q59284218 | ¿Qué es una variable de confusión? |
Search more.